• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCR/ABL signal transduction.

作者信息

Tauchi T, Broxmeyer H E

机构信息

Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202-5121, USA.

出版信息

Int J Hematol. 1995 Apr;61(3):105-12. doi: 10.1016/0925-5710(95)00361-u.

DOI:10.1016/0925-5710(95)00361-u
PMID:7599321
Abstract

A strong association between the Philadelphia chromosome (Ph1) and chronic myelogenous leukemia (CML) suggests that the Ph1 translocation plays a significant role in pathogenesis of CML. For this reason, Ph1-positive leukemias have been well studied from the molecular, clinical and cell biological perspective. In this review article, intracellular signalling events involving BCR/ABL fusion gene products are discussed in the context of the role of the Ph1 chromosome in human leukemia.

摘要

相似文献

1
BCR/ABL signal transduction.
Int J Hematol. 1995 Apr;61(3):105-12. doi: 10.1016/0925-5710(95)00361-u.
2
Molecular mechanisms of Bcr-Abl-induced oncogenesis.Bcr-Abl 诱导肿瘤发生的分子机制。
Cytokines Mol Ther. 1996 Dec;2(4):251-61.
3
Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.慢性髓性白血病的分子发病机制:对新治疗策略的启示
Ann Hematol. 1999 Feb;78(2):49-64. doi: 10.1007/s002770050473.
4
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.FTY720,一种治疗急变期慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的新选择。
J Clin Invest. 2007 Sep;117(9):2408-21. doi: 10.1172/JCI31095.
5
Molecular pathophysiology of chronic myelogenous leukemia.
Hematol Cell Ther. 1998 Oct;40(5):217-21.
6
The role of molecular techniques in the clinical management of leukemia. Lessons from the Philadelphia chromosome.
Cancer. 1992 Sep 15;70(6 Suppl):1695-700. doi: 10.1002/1097-0142(19920915)70:4+<1695::aid-cncr2820701608>3.0.co;2-d.
7
[Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].["应用“巢式”逆转录酶/聚合酶链反应检测Ph1染色体阳性白血病中的BCR-ABL融合基因"]
Zhonghua Yi Xue Za Zhi. 1994 Nov;74(11):662-5, 708.
8
Animal models of BCR/ABL-induced leukemias.BCR/ABL 诱导的白血病动物模型。
Leuk Lymphoma. 1993;11 Suppl 1:57-60. doi: 10.3109/10428199309047865.
9
[Molecular biological pathophysiology of chronic myelogenous leukemia].[慢性粒细胞白血病的分子生物学病理生理学]
Fukuoka Igaku Zasshi. 1995 Feb;86(2):19-23.
10
Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".具有典型临床和形态学特征的慢性粒细胞白血病可能为费城染色体阴性且“bcr阴性”。
Hematol Pathol. 1990;4(2):67-77.

引用本文的文献

1
Hsp90 N- and C-terminal double inhibition synergistically suppresses Bcr-Abl-positive human leukemia cells.热休克蛋白90(Hsp90)N端和C端的双重抑制协同抑制Bcr-Abl阳性人白血病细胞。
Oncotarget. 2017 Feb 7;8(6):10025-10036. doi: 10.18632/oncotarget.14324.
2
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.家族性腺瘤性息肉病合并慢性粒细胞白血病:对甲磺酸伊马替尼的反应。
J Gastroenterol. 2007 May;42(5):402-5. doi: 10.1007/s00535-007-2009-0. Epub 2007 May 25.
3
Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia.
甲磺酸伊马替尼联合其他化疗药物治疗慢性粒细胞白血病。
Int J Hematol. 2004 Jun;79(5):434-40. doi: 10.1532/ijh97.04013.
4
Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.环磷酸腺苷激动剂对Raf-1激酶的抑制作用会导致v-abl转化细胞的凋亡。
Mol Cell Biol. 1997 Jun;17(6):3229-41. doi: 10.1128/MCB.17.6.3229.